Sagopilone
Synthetic epothilone with antineoplastic activity
Sagopilone is a fully synthetic epothilone and a member of the class of antineoplastic agents. It was developed for its potential use in the treatment of various types of cancer. Sagopilone is notable for its ability to stabilize microtubules, which are essential components of the cytoskeleton in eukaryotic cells.
Chemical Structure and Properties[edit | edit source]
Sagopilone is a synthetic derivative of the natural product epothilone B. It is characterized by its complex macrolide structure, which includes a 16-membered lactone ring. The chemical structure of sagopilone allows it to bind to tubulin, promoting the polymerization of tubulin into microtubules and inhibiting their depolymerization.
Mechanism of Action[edit | edit source]
Sagopilone exerts its antitumor effects by stabilizing microtubules, similar to the mechanism of action of taxanes such as paclitaxel. By binding to the β-tubulin subunit of microtubules, sagopilone prevents their disassembly, leading to cell cycle arrest at the G2/M phase and ultimately inducing apoptosis in rapidly dividing cancer cells.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of sagopilone is characterized by its ability to penetrate the blood-brain barrier, making it a candidate for the treatment of central nervous system tumors. Sagopilone is metabolized primarily in the liver and is excreted via the biliary route.
Clinical Development[edit | edit source]
Sagopilone has undergone various phases of clinical trials to evaluate its efficacy and safety in treating different types of cancer, including breast cancer, ovarian cancer, and glioblastoma. Although initial studies showed promise, further development was halted due to strategic decisions by the developing company.
Potential Applications[edit | edit source]
Despite the cessation of its clinical development, sagopilone remains of interest in the scientific community for its unique properties and potential applications in cancer therapy. Its ability to cross the blood-brain barrier and its distinct mechanism of action compared to other microtubule-stabilizing agents make it a valuable compound for further research.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
